Register entry

Solis Pharmaceuticals Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
3
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

3

3 active NDC listings: 2 human prescription drug, 1 human otc drug. By marketing category: ANDA 2, OTC MONOGRAPH DRUG 1.

Dosage formNDCs
tablet2
patch1
RouteNDCs
oral2
topical1
Labeller name on the listingNDCs
solis pharmaceuticals inc.3
Catalogue

Marketed products

3
BrandGeneric nameForm / routeNDC
Dapsone 100mgDapsone 100mgtablet, oral85185-105ANDA
Dapsone 25mgDapsone 25mgtablet, oral85185-104ANDA
Maximum Strength 4% Lidocaine PatchLidocainepatch, topical85185-001OTC MONOGRAPH DRUG
Enquiry

Common questions

Is Solis Pharmaceuticals Inc. FDA approved?
Solis Pharmaceuticals Inc. holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Solis Pharmaceuticals Inc. make?
3 products are listed under Solis Pharmaceuticals Inc. in the openFDA NDC Directory, most often as tablet; patch. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.